Clinic-ready questionsNo medical record created

Peptide Consult Packet

Carry the context that helps a clinic give a useful answer without turning the platform into the prescriber.

Education and decision support. This release does not generate doses, injection instructions, cycles, diagnoses, prescriptions, or vendor pathways.

Prepared from this browser session

Peptide consultation packet

My decision profile

No assumptions yet; the library remains broad until you choose a goal or constraint.

Options I want to discuss

SemaglutideFDA approved for defined indications
TesamorelinFDA approved for a narrow indication

Questions for the clinician

  1. Which branded or compounded product are you proposing?
  2. What indication and candidacy criteria apply to me?
  3. How will side effects, nutrition, and follow-up be handled?
  4. What indication are you treating?
  5. How will IGF-1 and glucose be monitored?
  6. How does your proposal differ from the FDA-labeled use?

Verify the clinic offering

  • Confirm the exact product, indication, and route for Semaglutide.
  • Identify the prescribing clinician and administering credentials.
  • Explain product source, dispensing model, baseline evaluation, monitoring, and follow-up.
  • Provide total expected cost for the first 90 days, including consults, labs, medication, and follow-up.
  • Confirm the exact product, indication, and route for Tesamorelin.
This packet organizes questions and preferences. It does not contain a dose, route recommendation, cycle, diagnosis, or prescription.